Fisher & Paykel Healthcare Corporation Limited advises that all resolutions put to the company’s annual shareholders’ meeting held today were passed.

The seven resolutions were:

Resolution 1: To re-elect Neville Mitchell as a Director.
Resolution 2: To re-elect Lewis Gradon as a Director.
Resolution 3: To re-elect Lisa McIntyre as a Director.
Resolution 4: To re-elect Cather Simpson as a Director.
Resolution 5: To elect Mark Cross as a Director.
Resolution 6: To authorise the Directors to fix the fees and expenses of the company’s auditor.
Resolution 7: To approve the grant of discretionary long term variable remuneration instruments to Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2025.

All resolutions were decided by poll. The details of the total number of votes cast online, in person or by proxy on the polls were as follows:
 

Resolution	For	Against	Abstain
Resolution 1: Re-election of Neville Mitchell	429,216,814 97.36%	11,652,978 2.64%	1,299,617
Resolution 2: Re-election of Lewis Gradon	441,426,824 99.97%	139,173 0.03%	601,896
Resolution 3: Re-election of Lisa McIntyre	430,486,886 97.37%	11,642,888 2.63%	39,635
Resolution 4: Re-election of Cather Simpson	441,889,235 99.95%	243,087 0.05%	37,087
Resolution 5: Election of Mark Cross	437,480,939 98.98%	4,489,818 1.02%	198,652
Resolution 6: Approval of auditors’ fees and expenses	437,099,574 99.05%	4,211,623 0.95%	858,212
Resolution 7: Grant of discretionary long term variable remuneration instruments to Lewis Gradon	431,000,052 97.82%	9,625,215 2.18%	963,529

 

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.

 

Contacts:

Media Karen Knott GM Corporate Communications [email protected] +64 21 713 911   Investors Dan Adolph Head of Investor Relations [email protected] +64 22 511 4050

Authorised by Raelene Leonard, General Counsel and Company Secretary.